Fragile X screening by quantification of FMRP in dried blood spots by a luminex immunoassay

Journal of Molecular Diagnostics

Volumn 15, Issue 4, 2013, Pages 508-517

  Lafauci, Giuseppe ^a   Adayev, Tatyana ^a   Kascsak, Richard ^a   Kascsak, Regina ^a   Nolin, Sarah ^a   Mehta, Pankaj ^a   Brown, W Ted ^a   Dobkin, Carl ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MICROSPHERE;

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DNA DETERMINATION; DRIED BLOOD SPOT TESTING; FEMALE; FMR1 GENE; FRAGILE X SYNDROME; GENE; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOASSAY; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MOSAICISM; NEWBORN SCREENING; NONHUMAN; PROGNOSIS; QUANTITATIVE ANALYSIS; SEX DIFFERENCE;

DRIED BLOOD SPOT TESTING; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; IMMUNOASSAY; INFANT, NEWBORN; LYMPHOCYTES; MALE; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84879295924     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2013.02.006     Document Type: Article

References (60)

1. M. Pieretti, F.P. Zhang, Y.H. Fu, S.T. Warren, B.A. Oostra, C.T. Caskey, and D.L. Nelson Absence of expression of the FMR-1 gene in fragile X syndrome Cell 66 1991 817 822
2. K. De Boulle, A.J. Verkerk, E. Reyniers, L. Vits, J. Hendrickx, B. Van Roy, F. Van den Bos, E. de Graaff, B.A. Oostra, and P.J. Willems A point mutation in the FMR-1 gene associated with fragile X mental retardation Nat Genet 3 1993 31 35
3. B. Coffee, M. Ikeda, D.B. Budimirovic, L.N. Hjelm, W.E. Kaufmann, and S.T. Warren Mosaic FMR1 deletion causes fragile X syndrome and can lead to molecular misdiagnosis: a case report and review of the literature Am J Med Genet A 146A 2008 1358 1367
4. F. Tassone, R.J. Hagerman, D.N. Iklé, P.N. Dyer, M. Lampe, R. Willemsen, B.A. Oostra, and A.K. Taylor FMRP expression as a potential prognostic indicator in fragile X syndrome Am J Med Genet 84 1999 250 261
5. D. Devys, Y. Lutz, N. Rouyer, J.P. Bellocq, and J.L. Mandel The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation Nat Genet 4 1993 335 340
6. A.K. Gedeon, E. Baker, H. Robinson, M.W. Partington, B. Gross, A. Manca, B. Korn, A. Poustka, S. Yu, G.R. Sutherland, and J.C. Mulley Fragile X syndrome without CCG amplification has an FMR1 deletion Nat Genet 1 1992 341 344
7. S.C. Collins, S.M. Bray, J.A. Suhl, D.J. Cutler, B. Coffee, M.E. Zwick, and S.T. Warren Identification of novel FMR1 variants by massively parallel sequencing in developmentally delayed males Am J Med Genet A 152A 2010 2512 2520
8. S. Lévesque, C. Dombrowski, M.L. Morel, R. Rehel, J.S. Côté, J. Bussières, K. Morgan, and F. Rousseau Screening and instability of FMR1 alleles in a prospective sample of 24,449 mother-newborn pairs from the general population Clin Genet 76 2009 511 523
9. A. Cronister, J. Teicher, E.M. Rohlfs, A. Donnenfeld, and S. Hallam Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis Obstet Gynecol 111 2008 596 601
10. S.L. Nolin, S. Sah, A. Glicksman, S.L. Sherman, E. Allen, E. Berry-Kravis, F. Tassone, C. Yrigollen, A. Cronister, M. Jodah, N. Ersalesi, C. Dobkin, W.T. Brown, R. Shroff, G.J. Latham, and A.G. Hadd Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles Am J Med Genet A 161 2013 771 778
11. F. Tassone, R.J. Hagerman, W.D. Chamberlain, and P.J. Hagerman Transcription of the FMR1 gene in individuals with fragile X syndrome Am J Med Genet 97 2000 195 203
12. A. Kenneson, F. Zhang, C.H. Hagedorn, and S.T. Warren Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers Hum Mol Genet 10 2001 1449 1454
13. B. Primerano, F. Tassone, R.J. Hagerman, P. Hagerman, F. Amaldi, and C. Bagni Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations RNA 8 2002 1482 1488
14. M.M. Seltzer, M.W. Baker, J. Hong, M. Maenner, J. Greenberg, and D. Mandel Prevalence of CGG expansions of the FMR1 gene in a US population-based sample Am J Med Genet B Neuropsychiatr Genet 159 2012 589 597
15. F. Rousseau, A. Vincent, S. Rivella, D. Heitz, C. Triboli, E. Maestrini, S.T. Warren, G.K. Suthers, P. Goodfellow, J.L. Mandel, D. Toniolo, and I. Oberle Four chromosomal breakpoints and four new probes mark out a 10-cM region encompassing the fragile-X locus (FRAXA) Am J Hum Genet 48 1991 108 116
16. D.B. Bailey Jr., F.D. Armstrong, A.R. Kemper, D. Skinner, and S.F. Warren Supporting family adaptation to presymptomatic and "untreatable" conditions in an era of expanded newborn screening J Pediatr Psychol 34 2009 648 661
17. D. Skinner, S. Choudhury, J. Sideris, S. Guarda, A. Buansi, M. Roche, C. Powell, and D.B. Bailey Jr. Parents' decisions to screen newborns for FMR1 gene expansions in a pilot research project Pediatrics 127 2011 e1455 e1463
18. D.B. Bailey Jr. The blurred distinction between treatable and untreatable conditions in newborn screening Health Matrix Clevel 19 2009 141 153
19. A. Michalon, M. Sidorov, T.M. Ballard, L. Ozmen, W. Spooren, J.G. Wettstein, G. Jaeschke, M.F. Bear, and L. Lindemann Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice Neuron 74 2012 49 56
20. J.V. Mei, J.R. Alexander, B.W. Adam, and W.H. Hannon Use of filter paper for the collection and analysis of human whole blood specimens J Nutr 131 2001 1631S 1636S
21. F. Behets, M. Kashamuka, M. Pappaioanou, T.A. Green, R.W. Ryder, V. Batter, J.R. George, W.H. Hannon, and T.C. Quinn Stability of human immunodeficiency virus type 1 antibodies in whole blood dried on filter paper and stored under various tropical conditions in Kinshasa, Zaire J Clin Microbiol 30 1992 1179 1182
22. B.W. Adam, E.M. Hall, M. Sternberg, T.H. Lim, S.R. Flores, S. O'Brien, D. Simms, L.X. Li, V.R. De Jesus, and W.H. Hannon The stability of markers in dried-blood spots for recommended newborn screening disorders in the United States Clin Biochem 44 2011 1445 1450
23. L. Chen, S.W. Yun, J. Seto, W. Liu, and M. Toth The fragile X mental retardation protein binds and regulates a novel class of mRNAs containing U rich target sequences Neuroscience 120 2003 1005 1017
24. R.J. Kascsak, R. Fersko, D. Pulgiano, R. Rubenstein, and R.I. Carp Immunodiagnosis of prion disease Immunol Invest 26 1997 259 268
25. D.S. Spinner, R.B. Kascsak, G. Lafauci, H.C. Meeker, X. Ye, M.J. Flory, J.I. Kim, G.B. Schuller-Levis, W.R. Levis, T. Wisniewski, R.I. Carp, and R.J. Kascsak CpG oligodeoxynucleotide-enhanced humoral immune response and production of antibodies to prion protein PrPSc in mice immunized with 139A scrapie-associated fibrils J Leukoc Biol 81 2007 1374 1385
26. W.T. Brown The FRAXE Syndrome: is it time for routine screening? Am J Hum Genet 58 1996 903 905
27. S.L. Nolin, W.T. Brown, A. Glicksman, G.E. Houck Jr., A.D. Gargano, A. Sullivan, V. Biancalana, K. Bröndum-Nielsen, H. Hjalgrim, E. Holinski-Feder, F. Kooy, J. Longshore, J. Macpherson, J.L. Mandel, G. Matthijs, F. Rousseau, P. Steinbach, M.L. Väisänen, H. von Koskull, and S.L. Sherman Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles Am J Hum Genet 72 2003 454 464
28. S.L. Nolin, X.H. Ding, G.E. Houck, W.T. Brown, and C. Dobkin Fragile X full mutation alleles composed of few alleles: implications for CGG repeat expansion Am J Med Genet A 146A 2008 60 65
29. L. Chen, A. Hadd, S. Sah, S. Filipovic-Sadic, J. Krosting, E. Sekinger, R. Pan, P.J. Hagerman, T.T. Stenzel, F. Tassone, and G.J. Latham An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for southern blot analysis J Mol Diagn 12 2010 589 600
30. F. Tamanini, L.L. Kirkpatrick, J. Schonkeren, L. van Unen, C. Bontekoe, C. Bakker, D.L. Nelson, H. Galjaard, B.A. Oostra, and A.T. Hoogeveen The fragile X-related proteins FXR1P and FXR2P contain a functional nucleolar-targeting signal equivalent to the HIV-1 regulatory proteins Hum Mol Genet 9 2000 1487 1493
31. C. Iwahashi, F. Tassone, R.J. Hagerman, D. Yasui, G. Parrott, D. Nguyen, G. Mayeur, and P.J. Hagerman A quantitative ELISA assay for the fragile X mental retardation 1 protein J Mol Diagn 11 2009 281 289
32. M. Lessard, A. Chouiali, R. Drouin, G. Sebire, and F. Corbin Quantitative measurement of FMRP in blood platelets as a new screening test for fragile X syndrome Clin Genet 82 2012 472 477
33. M. Naseri Alterations of peripheral leukocyte count, erythrocyte sedimentation rate, and C-reactive protein in febrile urinary tract infection Iran J Kidney Dis 2 2008 137 142
34. M. Hudspeth, and H. Symons Hematology V.L. Gunn, C. Nechyba, The Harriet Lane handbook: A Manual for Pediatric House Officers ed 16. 2002 Mosby Philadelphia 294
35. Z.S. Huang, K.L. Chien, C.Y. Yang, K.S. Tsai, and C.H. Wang Peripheral differential leukocyte counts in humans vary with hyperlipidemia, smoking, and body mass index Lipids 36 2001 237 245
36. V.J. Karthikeyan, and G.Y. Lip White blood cell count and hypertension J Hum Hypertens 20 2006 310 312
37. S.H. Fatemi, T.J. Reutiman, T.D. Folsom, R.J. Rooney, D.H. Patel, and P.D. Thuras mRNA and protein levels for GABAAalpha4, alpha5, beta1 and GABABR1 receptors are altered in brains from subjects with autism J Autism Dev Disord 40 2010 743 750
38. S.H. Fatemi, and T.D. Folsom The role of fragile X mental retardation protein in major mental disorders Neuropharmacology 60 2011 1221 1226
39. D. Wöhrle, U. Salat, D. Gläser, J. Mücke, M. Meisel-Stosiek, D. Schindler, W. Vogel, and P. Steinbach Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats J Med Genet 35 1998 103 111
40. H.J. Smeets, A.P. Smits, C.E. Verheij, J.P. Theelen, R. Willemsen, I. van de Burgt, A.T. Hoogeveen, J.C. Oosterwijk, and B.A. Oostra Normal phenotype in two brothers with a full FMR1 mutation Hum Mol Genet 4 1995 2103 2108
41. R.J. Hagerman, C.E. Hull, J.F. Safanda, I. Carpenter, L.W. Staley, R.A. O'Connor, C. Seydel, M.M. Mazzocco, K. Snow, S.N. Thibodeau, D. Kuhl, D.L. Nelson, T. Caskey, and A.K. Taylor High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression Am J Med Genet 51 1994 298 308
42. S.L. Nolin, A. Glicksman, G.E. Houck Jr., W.T. Brown, and C.S. Dobkin Mosaicism in fragile X affected males Am J Med Genet 51 1994 509 512
43. I.L. Cohen, S.L. Nolin, V. Sudhalter, X.H. Ding, C.S. Dobkin, and W.T. Brown Mosaicism for the FMR1 gene influences adaptive skills development in fragile X-affected males Am J Med Genet 64 1996 365 369
44. C.S. Dobkin, S.L. Nolin, I. Cohen, V. Sudhalter, M.G. Bialer, X.H. Ding, E.C. Jenkins, N. Zhong, and W.T. Brown Tissue differences in fragile X mosaics: mosaicism in blood cells may differ greatly from skin Am J Med Genet 64 1996 296 301
45. C. Dobkin, N. Zhong, and W.T. Brown The molecular basis of fragile sites Am J Hum Genet 59 1996 478
46. B.R. Migeon The role of X inactivation and cellular mosaicism in women's health and sex-specific diseases JAMA 295 2006 1428 1433
47. R.J. Hagerman, and P.J. Hagerman The fragile X premutation: into the phenotypic fold Curr Opin Genet Dev 12 2002 278 283
48. J.M. Amos-Landgraf, A. Cottle, R.M. Plenge, M. Friez, C.E. Schwartz, J. Longshore, and H.F. Willard X chromosome-inactivation patterns of 1,005 phenotypically unaffected females Am J Hum Genet 79 2006 493 499
49. A.L. Reiss, L.S. Freund, T.L. Baumgardner, M.T. Abrams, and M.B. Denckla Contribution of the FMR1 gene mutation to human intellectual dysfunction Nat Genet 11 1995 331 334
50. D.Z. Loesch, R.M. Huggins, and R.J. Hagerman Phenotypic variation and FMRP levels in fragile X Ment Retard Dev Disabil Res Rev 10 2004 31 41
51. R. Willemsen, J. Levenga, and B.A. Oostra CGG repeat in the FMR1 gene: size matters Clin Genet 80 2011 214 225
52. R. Guthrie The origin of newborn screening Screening 1 1992 5 15
53. P.H. Corran, J. Cook, C. Lynch, H. Leendertse, A. Manjurano, J. Griffin, J. Cox, T. Abeku, T. Bousema, A.C. Ghani, C. Drakeley, and E. Riley Dried blood spots as a source of anti-malarial antibodies for epidemiological studies Malar J 7 2008 195
54. J.B. Moeschler, M. Shevell American Academy of Pediatrics Committee on Genetics Clinical genetic evaluation of the child with mental retardation or developmental delays Pediatrics 117 2006 2304 2316
55. D.B. Bailey Jr., D. Skinner, A.M. Davis, I. Whitmarsh, and C. Powell Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues Pediatrics 121 2008 e693 e704
56. E.D. Dodds, F. Tassone, P.J. Hagerman, and C.B. Lebrilla Polymerase chain reaction, nuclease digestion, and mass spectrometry based assay for the trinucleotide repeat status of the fragile X mental retardation 1 gene Anal Chem 81 2009 5533 5540
57. J. Yuhas, P. Walichiewicz, R. Pan, W. Zhang, E.M. Casillas, R.J. Hagerman, and F. Tassone High-risk fragile x screening in Guatemala: use of a new blood spot polymerase chain reaction technique Genet Test Mol Biomarkers 13 2009 855 859
58. F. Tassone, R. Pan, K. Amiri, A.K. Taylor, and P.J. Hagerman A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations J Mol Diagn 10 2008 43 49
59. I. Fernandez-Carvajal, P. Walichiewicz, X. Xiaosen, R. Pan, P.J. Hagerman, and F. Tassone Screening for expanded alleles of the FMR1 gene in blood spots from newborn males in a Spanish population J Mol Diagn 11 2009 324 329
60. B. Coffee, K. Keith, I. Albizua, T. Malone, J. Mowrey, S.L. Sherman, and S.T. Warren Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA Am J Hum Genet 85 2009 503 514